GlycoMimetics Appoints Boston Biomedical CEO Patricia S. Andrews to Its Board of Directors
“It’s an asset to our Board and
Ms. Andrews was named CEO of Boston Biomedical in
"I'm honored to serve on the Board of Directors of GlycoMimetics, which has impressed me with its management team and promising pipeline of treatments targeting some of today’s most serious medical challenges in oncology," said Ms. Andrews. "I believe these clinical assets have potential in areas of high unmet need, and I look forward to helping the company rapidly progress its drug candidates towards commercialization."
Ms. Andrews was introduced to
About GlycoMimetics, Inc.
This press release contains forward-looking statements regarding